Impaired monocyte activation in schizophrenia
Authors:
- Norbert MüllerNMNorbert Müller
- Jenny K. WagnerJWJenny K. Wagner
- Daniela KrauseDKDaniela Krause
- Elif WeidingerEWElif Weidinger
- Agnes WildenauerAWAgnes Wildenauer
- Michael ObermeierMOMichael Obermeier
- Sandra DehningSDSandra Dehning
- Rudolf GruberRGRudolf Gruber
- Markus J. SchwarzMSMarkus J. Schwarz
- 1 August 2012
- journal article
- Published by Elsevier in Psychiatry Research
- Vol. 198 (3) , 341-346
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Expression of anti-cardiolipin antibodies and inflammatory associated factors in patients with schizophreniaPsychiatry Research, 2011
- TLR ligands induce synergistic interferon-β and interferon-λ1 gene expression in human monocyte-derived dendritic cellsMolecular Immunology, 2011
- Impaired Neuroendocrine and Immune Response to Acute Stress in Medication-Naive Patients With a First Episode of PsychosisSchizophrenia Bulletin, 2010
- Neural injury following stroke: are Toll‐like receptors the link between the immune system and the CNS?British Journal of Pharmacology, 2010
- Apolipoprotein E inhibits Toll-like receptor (TLR)-3- and TLR-4-mediated macrophage activation through distinct mechanismsBiochemical Journal, 2010
- Neuroinflammation Associated with Aging Sensitizes the Brain to the Effects of Infection or StressNeuroimmunomodulation, 2008
- A Review of the Fetal Brain Cytokine Imbalance Hypothesis of SchizophreniaSchizophrenia Bulletin, 2008
- Editors' Introduction: Schizophrenia and ToxoplasmosisSchizophrenia Bulletin, 2007
- Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSFMolecular Psychiatry, 2004
- Higher Natural Killer Cell Activity in Schizophrenic Patients: The Impact of Serum Factors, Medication, and SmokingBrain, Behavior, and Immunity, 2000